# People Inc: financial statements, quarterly

PPLI · Nasdaq · CIK 1800227 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ppli.md) · [Financials](/companies/ppli/financials.md) · [Filings](/companies/ppli/filings.md) · [Insiders](/companies/ppli/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ppli/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,111](/filings/0001800227-24-000046.md) | [(388) d](/filings/0001628280-26-009997.md) | [624](/filings/0001800227-25-000028.md) | [634](/filings/0001800227-25-000124.md) | [642](/filings/0001628280-25-048244.md) | [721 d](/filings/0001628280-26-009997.md) | [482](/filings/0001628280-26-029798.md) | [443](/filings/0001628280-26-051881.md) | [590](/filings/0001628280-25-048244.md) | [646 d](/filings/0001628280-26-009997.md) | [423](/filings/0001628280-26-029798.md) | [437](/filings/0001628280-26-051881.md) |
| Cost of revenue | $m | [342](/filings/0001800227-24-000046.md) | [181 d](/filings/0001628280-26-009997.md) | [259](/filings/0001800227-25-000028.md) | [253](/filings/0001800227-25-000124.md) | [243](/filings/0001628280-25-048244.md) | [247 d](/filings/0001628280-26-009997.md) | [187](/filings/0001628280-26-029798.md) | [202](/filings/0001800227-25-000124.md) | [207](/filings/0001628280-25-048244.md) | [195 d](/filings/0001628280-26-009997.md) | [160](/filings/0001628280-26-029798.md) | not reported |
| Research and development | $m | [79.7](/filings/0001800227-24-000046.md) | [(13.0) d](/filings/0001628280-26-009997.md) | [63.2](/filings/0001800227-25-000028.md) | [53.4](/filings/0001800227-25-000124.md) | [53.9](/filings/0001628280-25-048244.md) | [57.8 d](/filings/0001628280-26-009997.md) | [35.7](/filings/0001628280-26-029798.md) | [34.2](/filings/0001628280-26-051881.md) | [49.5](/filings/0001628280-25-048244.md) | [46.5 d](/filings/0001628280-26-009997.md) | [39.7](/filings/0001628280-26-029798.md) | [33.7](/filings/0001628280-26-051881.md) |
| Operating income | $m | [(32.7)](/filings/0001800227-24-000046.md) | [(14.0) d](/filings/0001628280-26-009997.md) | [(63.4)](/filings/0001800227-25-000028.md) | [(21.5)](/filings/0001800227-25-000124.md) | [8.1](/filings/0001628280-25-048244.md) | [48.1 d](/filings/0001628280-26-009997.md) | [24.1](/filings/0001628280-26-029798.md) | [(7.5)](/filings/0001628280-26-051881.md) | [(20.4)](/filings/0001628280-25-048244.md) | [(113) d](/filings/0001628280-26-009997.md) | [(40.1)](/filings/0001628280-26-029798.md) | [(14.3)](/filings/0001628280-26-051881.md) |
| Interest expense | $m | [40.2](/filings/0001800227-23-000034.md) | [40.2 d](/filings/0001800227-24-000011.md) | [39.7](/filings/0001800227-24-000024.md) | [34.5](/filings/0001800227-25-000124.md) | [34.7](/filings/0001628280-25-048244.md) | [31.9 d](/filings/0001628280-26-009997.md) | [28.3](/filings/0001628280-26-029798.md) | [37.2](/filings/0001628280-26-051881.md) | [27.6](/filings/0001628280-25-048244.md) | [26.9 d](/filings/0001628280-26-009997.md) | [25.9](/filings/0001628280-26-029798.md) | [25.9](/filings/0001628280-26-051881.md) |
| Income tax | $m | [(119)](/filings/0001800227-24-000046.md) | [102 d](/filings/0001628280-26-009997.md) | [46.5](/filings/0001800227-25-000028.md) | [(40.4)](/filings/0001800227-25-000124.md) | [(86.2)](/filings/0001628280-25-048244.md) | [(61.8) d](/filings/0001628280-26-009997.md) | [(62.5)](/filings/0001628280-26-029798.md) | [74.4](/filings/0001628280-26-051881.md) | [(27.3)](/filings/0001628280-25-048244.md) | [78.3 d](/filings/0001628280-26-009997.md) | [(15.6)](/filings/0001628280-26-029798.md) | [177](/filings/0001628280-26-051881.md) |
| Net income | $m | [(391)](/filings/0001800227-24-000046.md) | [328 d](/filings/0001628280-26-009997.md) | [45.0](/filings/0001800227-25-000028.md) | [(142)](/filings/0001800227-25-000124.md) | [(244)](/filings/0001628280-25-048244.md) | [(199) d](/filings/0001628280-26-009997.md) | [(217)](/filings/0001628280-26-029798.md) | [211](/filings/0001628280-26-051881.md) | [(21.9)](/filings/0001628280-25-048244.md) | [(76.8) d](/filings/0001628280-26-009997.md) | [(71.9)](/filings/0001628280-26-029798.md) | [507](/filings/0001628280-26-051881.md) |
| Diluted EPS | $ per share | [(4.72)](/filings/0001800227-24-000046.md) | not reported | [0.51](/filings/0001800227-25-000028.md) | [(1.71)](/filings/0001800227-25-000124.md) | [(2.93)](/filings/0001628280-25-048244.md) | not reported | [(2.64)](/filings/0001628280-26-029798.md) | [2.57](/filings/0001628280-26-051881.md) | [(0.27)](/filings/0001628280-25-048244.md) | not reported | [(0.94)](/filings/0001628280-26-029798.md) | [6.68](/filings/0001628280-26-051881.md) |
| Basic EPS | $ per share | [(4.72)](/filings/0001800227-24-000046.md) | not reported | [0.52](/filings/0001800227-25-000028.md) | [(1.71)](/filings/0001800227-25-000124.md) | [(2.93)](/filings/0001628280-25-048244.md) | not reported | [(2.64)](/filings/0001628280-26-029798.md) | [2.64](/filings/0001628280-26-051881.md) | [(0.27)](/filings/0001628280-25-048244.md) | not reported | [(0.94)](/filings/0001628280-26-029798.md) | [6.78](/filings/0001628280-26-051881.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.3](/filings/0001800227-24-000046.md) | [0.9](/filings/0001628280-26-009997.md) | [1.1](/filings/0001800227-25-000028.md) | [1.2](/filings/0001800227-25-000124.md) | [1.3](/filings/0001628280-25-048244.md) | [1.4](/filings/0001628280-26-051881.md) | [1.1](/filings/0001628280-26-029798.md) | [1.1](/filings/0001628280-26-051881.md) | [1.0](/filings/0001628280-25-048244.md) | [0.9](/filings/0001628280-26-051881.md) | [1.1](/filings/0001628280-26-029798.md) | [1.1](/filings/0001628280-26-051881.md) |
| Current assets | $bn | [2.2](/filings/0001800227-23-000034.md) | [2.2](/filings/0001800227-25-000013.md) | [2.3](/filings/0001800227-24-000024.md) | [2.4](/filings/0001800227-24-000039.md) | [2.4](/filings/0001800227-24-000046.md) | [2.5](/filings/0001628280-26-009997.md) | [1.7](/filings/0001800227-25-000028.md) | [1.6](/filings/0001800227-25-000124.md) | [1.5](/filings/0001628280-25-048244.md) | [1.5](/filings/0001628280-26-051881.md) | [1.6](/filings/0001628280-26-029798.md) | [1.6](/filings/0001628280-26-051881.md) |
| Total assets | $bn | [10.0](/filings/0001800227-23-000034.md) | [10.4](/filings/0001800227-25-000013.md) | [10.4](/filings/0001800227-24-000024.md) | [10.2](/filings/0001800227-24-000039.md) | [9.8](/filings/0001800227-24-000046.md) | [9.7](/filings/0001628280-26-009997.md) | [7.2](/filings/0001800227-25-000028.md) | [7.4](/filings/0001800227-25-000124.md) | [7.2](/filings/0001628280-25-048244.md) | [7.2](/filings/0001628280-26-051881.md) | [6.8](/filings/0001628280-26-029798.md) | [7.5](/filings/0001628280-26-051881.md) |
| Current liabilities | $bn | [1.0](/filings/0001800227-23-000034.md) | [1.0](/filings/0001800227-25-000013.md) | [0.9](/filings/0001800227-24-000024.md) | [0.9](/filings/0001800227-24-000039.md) | [0.9](/filings/0001800227-24-000046.md) | [0.9](/filings/0001628280-26-009997.md) | [0.6](/filings/0001800227-25-000028.md) | [0.6](/filings/0001800227-25-000124.md) | [0.6](/filings/0001628280-25-048244.md) | [0.6](/filings/0001628280-26-051881.md) | [0.4](/filings/0001628280-26-029798.md) | [0.4](/filings/0001628280-26-051881.md) |
| Long-term debt | $bn | [2.0](/filings/0001800227-23-000034.md) | [2.0](/filings/0001800227-25-000013.md) | [2.0](/filings/0001800227-24-000024.md) | [2.0](/filings/0001800227-24-000039.md) | [2.0](/filings/0001800227-24-000046.md) | [1.4](/filings/0001628280-26-009997.md) | [1.4](/filings/0001800227-25-000028.md) | [1.4](/filings/0001800227-25-000124.md) | [1.4](/filings/0001628280-25-048244.md) | [1.4](/filings/0001628280-26-051881.md) | [1.4](/filings/0001628280-26-029798.md) | [1.4](/filings/0001628280-26-051881.md) |
| Current portion of debt | $bn | [0.0](/filings/0001800227-23-000034.md) | [0.0](/filings/0001800227-25-000013.md) | [0.0](/filings/0001800227-24-000024.md) | [0.0](/filings/0001800227-24-000039.md) | [0.0](/filings/0001800227-24-000046.md) | [0.0](/filings/0001628280-26-009997.md) | [0.0](/filings/0001800227-25-000028.md) | [0.0](/filings/0001800227-25-000124.md) | [0.0](/filings/0001628280-25-048244.md) | [0.0](/filings/0001628280-26-051881.md) | [0.0](/filings/0001628280-26-029798.md) | [0.0](/filings/0001628280-26-051881.md) |
| Shareholders' equity | $bn | [5.7](/filings/0001800227-23-000034.md) | [6.1](/filings/0001800227-25-000013.md) | [6.1](/filings/0001800227-24-000024.md) | [6.0](/filings/0001800227-24-000039.md) | [5.8](/filings/0001800227-24-000046.md) | [5.6](/filings/0001628280-26-009997.md) | [4.7](/filings/0001800227-25-000028.md) | [4.9](/filings/0001800227-25-000124.md) | [4.8](/filings/0001628280-25-048244.md) | [4.7](/filings/0001628280-26-051881.md) | [4.5](/filings/0001628280-26-029798.md) | [5.1](/filings/0001628280-26-051881.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [14.4 d](/filings/0001800227-24-000046.md) | [46.9 d](/filings/0001800227-25-000013.md) | [64.1](/filings/0001800227-24-000024.md) | [85.0 d](/filings/0001800227-24-000039.md) | [95.3 d](/filings/0001800227-24-000046.md) | [110 d](/filings/0001800227-25-000013.md) | [(27.3)](/filings/0001628280-26-029798.md) | [(7.1) d](/filings/0001628280-26-051881.md) | [61.9 d](/filings/0001628280-25-048244.md) | [36.6 d](/filings/0001628280-26-009997.md) | [10.0](/filings/0001628280-26-029798.md) | [45.7 d](/filings/0001628280-26-051881.md) |
| Capital expenditure | $m | [18.5 d](/filings/0001800227-24-000046.md) | [(33.0) d](/filings/0001628280-26-009997.md) | [2.9](/filings/0001800227-25-000028.md) | [3.4 d](/filings/0001800227-25-000124.md) | [3.4 d](/filings/0001628280-25-048244.md) | [5.3 d](/filings/0001628280-26-009997.md) | [4.1](/filings/0001628280-26-029798.md) | [4.0 d](/filings/0001628280-26-051881.md) | [5.8 d](/filings/0001628280-25-048244.md) | [5.2 d](/filings/0001628280-26-009997.md) | [8.0](/filings/0001628280-26-029798.md) | [11.2 d](/filings/0001628280-26-051881.md) |
| Share repurchases | $m | not reported | not reported | [0.0](/filings/0001800227-25-000028.md) | [0.0 d](/filings/0001800227-25-000124.md) | [0.0 d](/filings/0001628280-25-048244.md) | [0.0 d](/filings/0001628280-26-009997.md) | [179](/filings/0001628280-26-029798.md) | [20.6 d](/filings/0001628280-26-051881.md) | [100 d](/filings/0001628280-25-048244.md) | [15.0 d](/filings/0001628280-26-009997.md) | [124](/filings/0001628280-26-029798.md) | [9.7 d](/filings/0001628280-26-051881.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities, us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [86.0](/filings/0001800227-23-000034.md) | [88.4](/filings/0001800227-24-000024.md) | [83.1](/filings/0001800227-24-000039.md) | [82.8](/filings/0001800227-24-000046.md) | [85.9](/filings/0001800227-25-000028.md) | [83.1](/filings/0001800227-25-000124.md) | [83.2](/filings/0001628280-25-048244.md) | [82.2](/filings/0001628280-26-029798.md) | [82.2](/filings/0001628280-26-051881.md) | [79.6](/filings/0001628280-25-048244.md) | [76.7](/filings/0001628280-26-029798.md) | [75.9](/filings/0001628280-26-051881.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 0 at 2020-03-31, from the cover of the [10-Q filed 2020-06-03](/filings/0001800227-20-000004.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.